Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Whitney Wharton

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Hypertension (Dallas, Tex. : 1979)|September 7, 2022
Angiotensin Receptor Blockers and Dementia Prevention: Do Not RAS to a Conclusion YetSevil Yasar, Whitney Wharton
American Journal of Neurodegenerative Disease|February 6, 2013
Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's diseaseThomas Simon O'Hagan, Whitney Wharton, Patrick Gavin Kehoe
Journal of Alzheimer'S Disease : JAD|December 8, 2015
A Meta-Analysis of Alzheimer's Disease Incidence and Prevalence Comparing African-Americans and CaucasiansKyle Steenland, Felicia C Goldstein, Allan Levey, et al.
Plos One|November 2, 2018
The association of multiple anti-hypertensive medication classes with Alzheimer's disease incidence across sex, race, and ethnicityDouglas Barthold, Geoffrey Joyce, Whitney Wharton, et al.
SSRN|July 28, 2020
Caution on plasma cytokine findings in 2019 novel coronavirus casesWilliam T Hu, Whitney Wharton, Tugba Ozturk, et al.
Brain Research|April 23, 2013
Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS Cognitive and Affective sub study (KEEPS Cog)Whitney Wharton, Carey E Gleason, Virginia M Miller, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersIrene Yang, Kevin Hendler, Frank A Scannapieco, et al.
Menopause (New York, N.Y.)|December 31, 2011
Using predictors of hormone therapy use to model the healthy user bias: how does healthy user status influence cognitive effects of hormone therapy?Carey E Gleason, N Maritza Dowling, Elliot Friedman, et al.
Nature Communications|June 29, 2021
Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer's diseaseWilliam T Hu, Tugba Ozturk, Alexander Kollhoff, et al.
Experimental and Clinical Psychopharmacology|May 21, 2008
Oral contraceptives and androgenicity: influences on visuospatial task performance in younger individualsWhitney Wharton, Elliot Hirshman, Paul Merritt, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Hypertension (Dallas, Tex. : 1979)|September 7, 2022
Angiotensin Receptor Blockers and Dementia Prevention: Do Not RAS to a Conclusion YetSevil Yasar, Whitney Wharton
American Journal of Neurodegenerative Disease|February 6, 2013
Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's diseaseThomas Simon O'Hagan, Whitney Wharton, Patrick Gavin Kehoe
Journal of Alzheimer'S Disease : JAD|December 8, 2015
A Meta-Analysis of Alzheimer's Disease Incidence and Prevalence Comparing African-Americans and CaucasiansKyle Steenland, Felicia C Goldstein, Allan Levey, et al.
Plos One|November 2, 2018
The association of multiple anti-hypertensive medication classes with Alzheimer's disease incidence across sex, race, and ethnicityDouglas Barthold, Geoffrey Joyce, Whitney Wharton, et al.
SSRN|July 28, 2020
Caution on plasma cytokine findings in 2019 novel coronavirus casesWilliam T Hu, Whitney Wharton, Tugba Ozturk, et al.
Brain Research|April 23, 2013
Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS Cognitive and Affective sub study (KEEPS Cog)Whitney Wharton, Carey E Gleason, Virginia M Miller, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersIrene Yang, Kevin Hendler, Frank A Scannapieco, et al.
Menopause (New York, N.Y.)|December 31, 2011
Using predictors of hormone therapy use to model the healthy user bias: how does healthy user status influence cognitive effects of hormone therapy?Carey E Gleason, N Maritza Dowling, Elliot Friedman, et al.
Nature Communications|June 29, 2021
Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer's diseaseWilliam T Hu, Tugba Ozturk, Alexander Kollhoff, et al.
Experimental and Clinical Psychopharmacology|May 21, 2008
Oral contraceptives and androgenicity: influences on visuospatial task performance in younger individualsWhitney Wharton, Elliot Hirshman, Paul Merritt, et al.
Pageof 9